Recent publications · Crossref
5 total works indexed
- A global reference for human genetic variation
· 2015 · cited 17,400x
- 2018 ESC/EACTS Guidelines on myocardial revascularization
· 2018 · cited 5,456x
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
· 2017 · cited 3,854x
- Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
· 2018 · cited 3,068x
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial